首页> 外国专利> PHARMACEUTICAL COMPOSITION WITH CONTROLLED ACTIVE INGREDIENT DELIVERY FOR ACTIVE INGREDIENTS WITH GOOD SOLUBILITY IN WATER.

PHARMACEUTICAL COMPOSITION WITH CONTROLLED ACTIVE INGREDIENT DELIVERY FOR ACTIVE INGREDIENTS WITH GOOD SOLUBILITY IN WATER.

机译:活性成分受控的药物组合物,用于活性成分在水中具有良好溶解度的活性成分。

摘要

The invention relates to a pharmaceutical preparation comprising a) a core with an active ingredient and with an organic acid and/or with the salt of an organic acid; b) a coating which surrounds the core and which comprises content of polymer composed of (meth)acrylate copolymers having no more than 15% by weight of cationic or anionic groups, and which comprises at least 60% by weight of a (meth)acrylate copolymer which is composed of free-radical-polymerized units of from 93 to 98% by weight of C 1 -C 4 -alkyl esters of acrylic or methacrylic acid and from 7 to 2% by weight of (meth)acrylate monomers having a quaternary ammonium group in the alkyl radical, characterized in that the water-solubility of the active ingredient is at least 10 g/l at 20C and the coating comprises silicon dioxide particles whose average particle size is in the range from 1 to 50 mm.
机译:本发明涉及药物制剂,其包含:a)具有活性成分和有机酸和/或有机酸的盐的核; b)包围核的涂层,其包含由(甲基)丙烯酸酯共聚物组成的聚合物的含量,该聚合物具有不超过15重量%的阳离子或阴离子基团,并且包含至少60重量%的(甲基)丙烯酸酯由93-98%(重量)的丙烯酸或甲基丙烯酸的C 1 -C 4-烷基酯和7-2%(重量)的具有季铵盐的(甲基)丙烯酸酯单体的自由基聚合单元组成的共聚物烷基中的铵基,其特征在于活性成分在20℃的水溶性至少为10g / l,并​​且包衣包含平均粒径为1至50mm的二氧化硅颗粒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号